Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease
NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases
About This Grant
Individuals with chronic kidney disease (CKD) are often burdened with complex medication regimens, polypharmacy, and comorbidities, and thus commonly experience medication therapy problems (MTPs). MTPs are undesirable events experienced by patients that involve medication therapy and may result in suboptimal disease management, harm, or risk of harm; this includes omission of clinically indicated medications. For example, people with CKD often do not receive important guideline-recommended cardio-kidney protective medications. Up to 30-40% of US adults with CKD lack ACEi/ARB or statin therapy. Further, newer cardiokidney protective medications, such as SGL T2i or GLP1 RA, are widely underutilized in people with CKD, and nephrology-based prescribing of these therapies is particularly low. Collaboration with pharmacists in the nephrology clinic setting is a potential way to improve use of guideline-recommended cardio-kidney protective medications and address MTPs for individuals with CKD. The objectives of this proposal are to discover ways to optimize medication therapy in nephrology clinics, design and build a pharmacist-led population health management (PHM)-based intervention with end-user stakeholders, and test the intervention in a pilot trial. The specific aims are to: 1) Identify needs that would facilitate nephrology-based prescribing of guidelinerecommended cardio-kidney protective medications through stakeholder interviews; 2) Develop a stakeholderinformed intervention to address nephrology-based prescribing of guideline-recommended cardio-kidney protective medications for CKD; and 3) Test the feasibility and acceptability of the intervention in a pilot trial. Preliminary data generated from this research will support a future R-level application to evaluate pharmacistled interventions in a randomized clinical trial. This K23 award will support the training and career development of Melanie Weitman, PharmD. Dr. Weltman's career goal is to become an independent investigator who leverages pharmacy care practice to enhance CKD care, increase access to guideline-recommended medication therapy, and improve medication-related outcomes for individuals with CKD. Dr. Weitman will achieve this goal through support of her experienced mentoring team, which includes experts in population health management, pragmatic clinical trial design and implementation, and multidisciplinary care models. Specifically, this proposal will enable Dr. Weitman to achieve the following career development objectives: develop skills in 1) qualitative methodology and 2) human-centered design and intervention development; and 3) refine expertise in clinical trial design and data analysis. Dr. Weitman will also pursue overarching career development activities to strengthen leadership and academic contributions. Completion of these aims and objectives will facilitate Dr. Weltman's transition to becoming an independent investigator and leader in medication-related outcomes research in CKD.
Grant Summary
Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease is a NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases grant providing up to $190K for university, nonprofit, healthcare org. Applications are due 2031-02-28 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $190K
2031-02-28
- 1Confirm your organization is eligible for Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease: Frequently Asked Questions
Who is eligible for the Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease?
Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease is offered by NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease provide?
Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease provides up to $190K per award from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease deadline?
Applications for Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease are due 2031-02-28 (open). Because deadlines can change, verify the date with the funder, NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease?
To apply for Development and Testing of a Pharmacist Led Population Health Management Program to Optimize Guideline Recommended Medication Therapy in Chronic Kidney Disease, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases.